We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRE
576
DELISTED
Duke Realty Corp.
DRE
| $7.45M | 0.02% |
433,495
+16,560
| +4% | +$299K |
|
|
LM
577
DELISTED
Legg Mason, Inc.
LM
| $7.41M | 0.02% |
144,751
-6,179
| -4% | -$307K |
|
578
Community Health Systems
CYH
$393M
| $7.39M | 0.02% |
163,250
+521
| +0.3% | +$21.7K |
|
|
SBNY
579
DELISTED
Signature Bank
SBNY
| $7.36M | 0.02% |
65,719
+1,706
| +3% | +$201K |
|
|
TSS
580
DELISTED
Total System Services, Inc.
TSS
| $7.35M | 0.02% |
237,544
-98,331
| -29% | -$3.11M |
|
|
SPN
581
DELISTED
Superior Energy Services, Inc.
SPN
| $7.35M | 0.02% |
22,354
+57
| +0.3% | +$19.7K |
|
|
HOLX
582
DELISTED
Hologic
HOLX
| $7.35M | 0.02% |
301,974
-18,643
| -6% | -$471K |
|
583
MSCI
MSCI
$41.6B
| $7.34M | 0.02% |
156,040
+698
| +0.4% | +$32.3K |
|
584
SM Energy
SM
$7.8B
| $7.31M | 0.02% |
93,752
+1,905
| +2% | +$155K |
|
585
Avnet
AVT
$7.29B
| $7.31M | 0.02% |
176,190
+1,517
| +0.9% | +$66.1K |
|
586
Jazz Pharmaceuticals
JAZZ
$15.9B
| $7.29M | 0.02% |
45,411
-2,358
| -5% | -$363K |
|
587
Brunswick
BC
$5.13B
| $7.28M | 0.02% |
172,863
+1,030
| +0.6% | +$43.6K |
|
|
TRW
588
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $7.28M | 0.02% |
71,935
-487
| -0.7% | -$48.7K |
|
589
Annaly Capital Management
NLY
$17.1B
| $7.28M | 0.02% |
170,376
+10,283
| +6% | +$470K |
|
590
Ingredion
INGR
$6.27B
| $7.25M | 0.02% |
95,729
+740
| +0.8% | +$57.5K |
|
|
CBST
591
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $7.17M | 0.02% |
108,141
+2,652
| +3% | +$174K |
|
592
National Fuel Gas
NFG
$7.82B
| $7.15M | 0.02% |
102,201
+1,080
| +1% | +$79.1K |
|
|
QEP
593
DELISTED
QEP RESOURCES, INC.
QEP
| $7.14M | 0.02% |
232,027
-10,043
| -4% | -$336K |
|
594
Cullen/Frost Bankers
CFR
$10.3B
| $7.14M | 0.02% |
93,268
+513
| +0.6% | +$40.3K |
|
595
West Pharmaceutical
WST
$24B
| $7.11M | 0.02% |
158,824
+11,675
| +8% | +$496K |
|
596
WEX
WEX
$6.37B
| $7.11M | 0.02% |
64,402
+69
| +0.1% | +$7.58K |
|
597
UGI
UGI
$7.74B
| $7.1M | 0.02% |
208,217
+2,939
| +1% | +$100K |
|
598
Pediatrix Medical
MD
$2.18B
| $7.1M | 0.02% |
129,458
-1,843
| -1% | -$105K |
|
599
Huntington Ingalls Industries
HII
$12.9B
| $7.1M | 0.02% |
68,091
-1,045
| -2% | -$103K |
|
|
CTRX
600
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $7.07M | 0.02% |
167,620
-273
| -0.2% | -$12.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.